- Home
- / Smith & Nephew
- / Revenue
Smith & Nephew revenue increased from £3.6 billion in 2017 to £3.7 billion in 2018, a (2.9%) increase.
Annual Revenue (£)
Smith & Nephew revenue was £3.72 b in FY, 2018 which is a (2.9%) year over year increase from the previous period.
| FY, 1996 | FY, 1997 | FY, 1998 | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | £1.07 b | £1.05 b | £1.05 b | £1.12 b | £1.13 b | £1.08 b | £1.11 b | £1.18 b | £1.25 b | £1.41 b | £1.42 b | £2.04 b | £2.87 b | £3.17 b | £3.58 b | £3.39 b | £3.61 b | £3.72 b |
| Growth | (1.97%) | 0.51% | 6.31% | 1.32% | (4.67%) | 2.61% | 6.22% | 5.90% | 12.70% | 0.92% | 43.37% | 10.53% | 13.04% | (5.37%) | 6.61% | 2.92% |
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other
| FY, 2016 | |
|---|---|
| Advanced Wound Devices | 4 |
| Sports Medicine Joint Repair | 13 |
| Arthroscopic Enabling Technologies | 14 |
| Trauma & Extremities | 10 |
| Other Surgical Businesses | 5 |
| Knee Implants | 20 |
| Hip Implants | 13 |
| Advanced Wound Care | 15 |
| Advanced Wound Bioactives | 7 |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.